AMRS - Amyris, Inc.
4.2100 0.00 (0.00%)
After hours: 4:58PM EDT
| Previous Close | 4.2400 |
| Open | 4.2000 |
| Bid | 4.2000 x 4000 |
| Ask | 4.3000 x 800 |
| Day's Range | 4.0000 - 4.2300 |
| 52 Week Range | 1.8700 - 9.2900 |
| Volume | 790,467 |
| Avg. Volume | 3,081,040 |
| Market Cap | 412.968M |
| Beta (3Y Monthly) | 1.32 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.5220 |
| Earnings Date | Aug 5, 2019 - Aug 9, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.00 |
- ACCESSWIRE•9 hours ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. - AMRS
NEW YORK, NY / ACCESSWIRE / May 23, 2019 / Pomerantz LLP is investigating claims on behalf of investors of Amyris, Inc. ("Amyris" or the "Company") (AMRS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether Amyris and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
GlobeNewswire•14 hours agoAmyris Teams Up with Model and Businesswoman Rosie Huntington-Whiteley as Brand Partner for its Pipette Baby Brand
Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that Rosie Huntington-Whiteley, the British supermodel, designer, businesswoman, and mother, is joining Amyris’s Pipette baby brand as its new brand partner to drive awareness and sales. Huntington-Whiteley will also serve on Pipette’s advisory board to help guide the brand to meet the needs of parents through clean, effective, and sustainable baby care products. Pipette will officially launch in August 2019 and is expected to be available at large online and brick-and-mortar mass retailers.
- ACCESSWIRE•yesterday
IMPORTANT SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 22, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 15, 2018 and March 19, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before June 3, 2019.
- ACCESSWIRE•yesterday
Zhang Investor Law Reminds Investors of June 3 Deadline in Securities Class Action Lawsuit Against Amyris, Inc. - AMRS
NEW YORK, NY / ACCESSWIRE / May 22, 2019 / Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Amyris, Inc. (NASDAQ: AMRS) from March 15, 2018 ...
- GlobeNewswire•yesterday
AMRS DEADLINE: Pawar Law Group Reminds Investors of June 3 Deadline In Securities Class Action Lawsuit Against Amyris, Inc. – AMRS
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Amyris, Inc. (AMRS) from March 15, 2018 and March 19, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Amyris investors under the federal securities laws. The firm reminds investors of the June 3, 2019 lead plaintiff deadline. To join the Amyris class action, go to http://pawarlawgroup.com/cases/amyris-inc/ or call Vik Pawar, Esq.
- ACCESSWIRE•2 days ago
Amyris, Inc. (AMRS), Zogenix, Inc. (ZGNX) & Taronis Technologies, Inc. f/k/a MagneGas Applied Technology (TRNX) - Bronstein, Gewirtz & Grossman, LLC Announces Class Action
NEW YORK, NY / ACCESSWIRE / May 22, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed againstthe following publicly-traded companies. You can review ...
- Motley Fool•2 days ago
Can Amyris Succeed With Its Latest Turnaround?
The company hopes new products in development and a reshuffled debt portfolio can deliver long-awaited growth and profits. Investors have heard that before.
- ACCESSWIRE•2 days ago
IMPORTANT DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 21, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 15, 2018 and March 19, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before June 3, 2019.
- GlobeNewswire•2 days ago
Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Amyris, Inc. Investors
Important Deadline Reminder: Investors who purchased Amyris securities during the Class Period may, no later than June 3, 2019, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please visit www.ktmc.com/amyris-inc-securities-class-action.
- GlobeNewswire•2 days ago
Amyris to Present at B. Riley FBR 20th Annual Institutional Investor Conference on Thursday, May 23, 2019
Amyris will provide an update on its business during the presentation, which is scheduled for Thursday, May 23, at 12:30 p.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company’s website at http://investors.amyris.com. Amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products.
- GlobeNewswire•2 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amyris, Inc. – AMRS
Pomerantz LLP is investigating claims on behalf of investors of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext.
- GlobeNewswire•3 days ago
Amyris Announces the Execution of Strategic Supply Agreements with Raízen, the Largest Sugar Producer in the World
Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the execution of strategic supply agreements with Raízen for the supply of sugar, energy and other utilities to its new planned production plant co-located with Raízen’s Barra Mill at Barra Bonita, Brazil. In addition to the supply agreements, the companies entered into an arrangement to establish the basis for the creation of a potential joint venture between Amyris and Raízen, focused on the production and commercialization on a global basis of zero calorie sweeteners using Amyris’s leading technology, naturally sourced from sugar cane sugar.
- GlobeNewswire•3 days ago
Amyris Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has received a standard notice from Nasdaq stating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarter ended March 31, 2019, and because it remains delinquent in filing its annual report on Form 10-K for the year ended December 31, 2018, it is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financing reports with the Securities and Exchange Commission. The Nasdaq notice has no immediate effect on the listing or trading of Amyris’s common stock on the Nasdaq Global Select Market.
- GlobeNewswire•3 days ago
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Amyris, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Amyris, Inc. (“Amyris” or the “Company”) (AMRS) of the June 3, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you invested in Amyris stock or options between March 15, 2018 and March 19, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/AMRS. There is no cost or obligation to you.
- GlobeNewswire•3 days ago
SHAREHOLDER ALERT - Amyris, Inc. (AMRS) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: June 3, 2019
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Amyris, Inc. (“Amyris” or the “Company”) (AMRS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Amyris securities between March 15, 2018 and March 19, 2019, both dates inclusive. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
- ACCESSWIRE•4 days ago
SHAREHOLDER ALERT - Amyris, Inc. (AMRS) Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: June 3, 2019
NEW YORK, NY / ACCESSWIRE / May 20, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Amyris, Inc. ("Amyris" or the "Company") ...
- GlobeNewswire•4 days ago
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. (“Amyris” or “the Company”) (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
- GlobeNewswire•4 days ago
Amyris Announces Receipt of $10 Million Payment from LAVVAN for Delivering on First Major CBD Milestone
Amyris, Inc. (AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has received from its cannabinoid partner, LAVVAN, a first cash payment of $10 million for having successfully delivered on its first major collaboration milestone as announced on March 29, 2019. “We are very pleased with the continued strong execution of our business strategy and the performance of our technology platform,” said John Melo, President and CEO of Amyris. “We are also encouraged by the progress we’ve made thus far working with our valued partner, LAVVAN, and our collaborative relationship with them on this project, which will be another cornerstone of our growth.
- GlobeNewswire•6 days ago
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS AMRS, BV, FLEX, REV of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, May 17, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
- ACCESSWIRE•6 days ago
DEADLINE RAPIDLY APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Amyris, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 17, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Amyris, Inc. ("Amyris" or "the Company") (NASDAQ: AMRS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 15, 2018 and March 19, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before June 3, 2019.
- GlobeNewswire•7 days ago
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Amyris, Flex, comScore, and Mueller Water and Encourages Investors to Contact the Firm
NEW YORK, May 16, 2019 -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Amyris, Inc., Flex Ltd.,.
- GlobeNewswire•7 days ago
AMRS NOTICE: Zhang Investor Law Reminds Investors of June 3 Deadline in Securities Class Action Lawsuit Against Amyris, Inc. – AMRS
Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Amyris, Inc. (AMRS) from March 15, 2018 and March 19, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Amyris investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than June 3, 2019.
- GlobeNewswire•7 days ago
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Amyris, Inc.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming June 3, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ: AMRS) investors who purchased securities between March 15, 2018, and March 19, 2019, inclusive (the “Class Period”). If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.
